Oncotype DX Breast Recurrence Score Assay after TAILORx and RxPONDER: What’s Next? אונקוטסט 33:23 1 year ago 5 021 Скачать Далее
Oncotype DX – Do I Need a Breast Cancer Gene-Expression Assay? Yerbba – Breast Cancer 5:24 3 years ago 3 940 Скачать Далее
Should You Have an Oncotype DX Test for Breast Cancer? All You Need to Know Yerbba – Breast Cancer 7:44 6 months ago 7 049 Скачать Далее
Steve Shak, ASCO 2020: The Oncotype DX Breast Recurrence Score® Test Touch Medical Media Services 8:23 4 years ago 3 669 Скачать Далее
RxPONDER: sparing chemotherapy in node-positive early-stage breast cancer VJOncology 2:50 3 years ago 1 657 Скачать Далее
Outcomes Matter -- oncotype DX® Exact Sciences Precision Oncology 2:07 2 years ago 2 139 Скачать Далее
The role of the Oncotype DX assay in the management of patients with breast cancer VJOncology 0:38 1 year ago 298 Скачать Далее
TAILORx: an update incl 12-year event rates in woman with ER+ lymph node-negative breast cancer VJOncology 5:19 1 year ago 1 502 Скачать Далее
RxPONDER: 21-gene assay informs chemotherapy benefit in HR+ node-positive breast cancer VJOncology 0:38 1 year ago 162 Скачать Далее
The Latest: What To Do If You Have An Intermediate Oncotype Recurrence Score DowlingDennis 13:39 10 years ago 6 033 Скачать Далее
Genomic Testing During Breast Cancer: Should You Have Testing? Yerbba – Breast Cancer 14:21 4 months ago 3 675 Скачать Далее
The impact of the Oncotype DX® Recurrence Score® on treatment decisions in breast cancer patients EMJ 5:47 9 years ago 288 Скачать Далее
RxPONDER: sparing chemotherapy in node-positive early-stage breast cancer VJOncology 3:08 3 years ago 1 036 Скачать Далее
How is the Oncotype DX Assay Used In Planning Breast Cancer Treatment? Breast Cancer Answers® 8:11 10 years ago 251 Скачать Далее
The value of an intermediate Recurrence Score® result in the Oncotype DX® Breast Cancer Assay EMJ 1:27 8 years ago 515 Скачать Далее
